Memorial Sloan Kettering Cancer Center

This study is testing whether combining two targeted drugs, inotuzumab and blinatumomab, is a safe and effective first treatment for adults with a type of blood cancer called B-cell acute lymphoblastic leukemia (B-ALL). It is specifically for patients aged 55 and older, or younge…

This early-stage study is testing the safety of a new radioactive drug designed to target and deliver radiation directly to specific cancer cells. It will involve 12 adults with advanced, hard-to-treat neuroendocrine cancers of the lung or prostate that have worsened after standa…

This study is testing whether a short, precise course of radiation combined with immunotherapy drugs can shrink aggressive bladder tumors before surgery to remove the bladder. It is for patients whose cancer has grown into the muscle wall and who cannot or choose not to receive s…

This study is testing whether a specialized form of talk therapy, called Meaning-Centered Psychotherapy for Latinos (MCP-L), can better reduce anxiety and depression and improve quality of life for Mexican patients with advanced breast, prostate, colorectal, or thyroid cancer. It…

This study aims to find out if simple voice recordings from a smartphone can help detect a serious brain side effect called ICANS in patients receiving CAR T-cell therapy for lymphoma or multiple myeloma. Researchers will collect voice recordings and daily brain function assessme…